Reviva Pharmaceuticals Holdings, Inc. (RVPHW)の価格はいくらですか

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)の価格は$0.003です

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)の時価総額は何ですか

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)の時価総額は$343.91Kです

Reviva Pharmaceuticals Holdings, Inc.（RVPHW）の株価履歴

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

年	パフォーマンス
2026 (TTM)	305.88%
2025	-96.70%
2024	-75.67%
2023	0.82%
2022	134.68%
2021	-39.09%
2020	167.36%
2019	-15.00%
2018	0.00%

年

パフォーマンス

2026 (TTM)

305.88%

2025

-96.70%

2024

-75.67%

2023

0.82%

2022

134.68%

2021

-39.09%

2020

167.36%

2019

-15.00%

2018

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$517.18	32.51%	US
Argenx SE ARGX.US	$857.76	31.47%	NL
Lonza Group AG LONN.SW	$745.22	9.11%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$258.46	14.18%	BE

企業

株価

変化率 1年%

国